BioNTech and Pfizer raised 2021’s production target for their Covid-19 vaccine to as many as 2.5-billion doses, with the German biotech company’s chief predicting a version of the shot that can be stored in refrigerators will be ready within months.
The new target represents an increase of about one-quarter from the company’s earlier estimate...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.